Expanded Use of Transcatheter Aortic Valve Replacement in Patients with Low Surgical Risk

References

[1] Otto CM, Newby DE, Hillis GS.Calcific aortic stenosis: a review. JAMA. 2024. Vol. 332(23):2014-26

[2] Writing Committee Members. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, et al.. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021. Vol. 77(4):e25-197

[3] Minakata K, Tanaka S, Okawa Y, Kaneko T, Okonogi S, Usui A, et al.. Twenty-year outcome of aortic valve replacement with St. Jude Medical mechanical valves in Japanese patients. Circ J. 2015. Vol. 79(11):2380-8

[4] Goldstone AB, Chiu P, Baiocchi M, Lingala B, Patrick WL, Fischbein MP, et al.. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med. 2017. Vol. 377(19):1847-57

[5] Bowdish ME, Mehaffey JH, Chang SC, O’Gara PT, Mack MJ, Goldstone AB, et al.. Bioprosthetic vs mechanical aortic valve replacement in patients 40 to 75 years of age. J Am Coll Cardiol. 2025. Vol. 85(12):1289-98

[6] Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al.. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022. Vol. 43(7):561-632

[7] Waksman R, Rogers T, Torguson R, Gordon P, Ehsan A, Wilson SR, et al.. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis. J Am Coll Cardiol. 2018. Vol. 72(18):2095-105

[8] Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al.. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019. Vol. 380(18):1695-705

[9] Mack MJ, Leon MB, Thourani VH, Pibarot P, Hahn RT, Genereux P, et al.. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med. 2023. Vol. 389(21):1949-60

[10] Leon MB, Mack MJ, Pibarot P, Hahn RT, Thourani VH, Kodali SH, et al.. Transcatheter or surgical aortic-valve replacement in low-risk patients at 7 years. N Engl J Med. 2025.

[11] Jørgensen TH, Thyregod HGH, Ihlemann N, Nissen H, Petursson P, Kjeldsen BJ, et al.. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021. Vol. 42(30):2912-9

[12] Thyregod HG, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al.. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015. Vol. 65(20):2184-94

[13] Thyregod HG, Jørgensen TH, Ihlemann N, Steinbrüchel DA, Nissen H, Kjeldsen BJ, et al.. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J. 2024. Vol. 45(13):1116-24

[14] Blankenberg S, Seiffert M, Vonthein R, Baumgartner H, Bleiziffer S, Borger MA, et al.. Transcatheter or surgical treatment of aortic-valve stenosis. N Engl J Med. 2024. Vol. 390(17):1572-83

[15] Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al.. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019. Vol. 380(18):1706-15

[16] Forrest JK, Deeb GM, Yakubov SJ, Gada H, Mumtaz MA, Ramlawi B, et al.. 4-Year outcomes of patients with aortic stenosis in the evolut low risk trial. J Am Coll Cardiol. 2023. Vol. 82(22):2163-5

[17] Badertscher P, Stortecky S, Serban T, Knecht S, Heg D, Tueller D, et al.. Long-term outcomes of patients requiring pacemaker implantation after transcatheter aortic valve replacement: the SwissTAVI Registry. JACC Cardiovasc Interv. 2025. Vol. 18(9):1163-71

[18] Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, et al.. 5-Year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis. J Am Coll Cardiol. 2025. Vol. 85(15):1523-32

[19] Mehaffey JH, Jagadeesan V, Kawsara M, Hayanga JWA, Chauhan D, Wei L, et al.. Transcatheter vs surgical aortic valve replacement in bicuspid aortic valves. Ann Thorac Surg. 2025. Vol. 119(6):1261-9

[20] Saad M, Seoudy H, Frank D. Challenging anatomies for TAVR-bicuspid and beyond. Front Cardiovasc Med. 2021. Vol. 8:654554

[21] Landes U, Sathananthan J, Witberg G, De Backer O, Sondergaard L, Abdel-Wahab M, et al.. Transcatheter replacement of transcatheter versus surgically implanted aortic valve bioprostheses. J Am Coll Cardiol. 2021. Vol. 77(1):1-14

[22] Windecker S, Okuno T, Unbehaun A, Mack M, Kapadia S, Falk V. Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation? Eur Heart J. 2022. Vol. 43(29):2729-50

[23] Hawkins RB, Deeb GM, Sukul D, Patel HJ, Gualano SK, Chetcuti SJ, et al.. Redo surgical aortic valve replacement after prior transcatheter versus surgical aortic valve replacement. JACC Cardiovasc Interv. 2023. Vol. 16(8):942-53

[24] Vekstein AM, Salah HM, Stebbins A, Wegermann Z, Yankey GS Jr, Kosinski A, et al.. Outcomes of transcatheter aortic valve replacement in low-risk patients in the United States: a report from the STS/ACC TVT Registry. Circulation. 2025. Vol. 151(16):1134-46